REMEDY : BNSSG referral pathways & Joint Formulary


Home > Children & Young People > Endocrinology >

Endocrine Services

Checked: 23-12-2018 by Vicky Ryan Next Review: 23-12-2019

Service Overview

The Bristol Royal Hospital for Children offer a comprehensive specialist outpatient and inpatient service for the management of all secondary and tertiary paediatric endocrine conditions. This includes assessment of growth and puberty disorders and other complex hormone problems

In addition to the frequent conditions listed below, the multidisciplinary endocrine team have expertise in bone and calcium disorders, endocrine late-effects of cancer and its treatment, endocrine effects of a variety of chronic childhood diseases and head injury.

  • Growth disorders - short stature, tall stature
  • Pituitary disorders
  • Thyroid disorders
  • Adrenal disorders
  • Unduly early or late puberty
  • Hypoglycaemia
  • Abnormalities in calcium metabolism
  • Diabetes
  • Obesity

Treatments offered for Diabetes: children and adolescents receive multidisciplinary diabetes care from diabetes nurse specialists, consultants, paediatric dieticians to support them to optimise their blood glucose control and their physical, psychological, intellectual, educational and social development. See the Remedy page on Children, Diabetes Mellitus

Referrals to the paediatric endocrine team can be made via the e-Referral system.

To contact the team please call: 0117 342 0165 or 0117 342 0203.

For further details see the UHB website

 

 



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.